Beneficial effects of L-carnitine in dialysis patients with impaired left ventricular function: An observational study

Current Medical Research and Opinion

Volumn 18, Issue 3, 2002, Pages 172-175

  Romagnoli, G F ^a   Naso, A ^a   Carraro, G ^a   Lidestri, V ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Haemodialysis; L Carnitine; Left ventricular dysfunction

Indexed keywords

CARNITINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DIALYSIS; DRUG EFFECT; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; M MODE ECHOCARDIOGRAPHY; MALE; TWO DIMENSIONAL ECHOCARDIOGRAPHY; CHRONIC KIDNEY FAILURE; ECHOCARDIOGRAPHY; ECHOGRAPHY; MIDDLE AGED; OBSERVATION; RENAL REPLACEMENT THERAPY; TREATMENT OUTCOME;

AGED; CARNITINE; ECHOCARDIOGRAPHY; FEMALE; HUMAN; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGE; OBSERVATION; RENAL DIALYSIS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; HUMANS; MIDDLE AGED;

EID: 0035991593     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079902125000606     Document Type: Article

References (25)

1. L-carnitine in dialysis patients
2. Quantitative assessment of carnitine loss during haemodialysis and haemofiltration
3. Carnitine metabolism in short- and long-term maintenance hemodialysis
4. A comparison in plasma and muscle carnitine levels in patients on peritoneal or hemodialysis for chronic renal failure
5. Potential role of carnitine in patients with renal insufficiency
6. Multicenter trial of L-carnitine in maintenance hemodialysis patients
7. Pharmacokinetics of L-carnitine in patients with end-stage disease undergoing long-term hemodialysis
8. Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors
9. Morbidity and mortality on maintenance hemodialysis
10. L-carnitine: A preliminary review of its pharmacokinetics, and its therapeutic use in ischaemic cardiac disease and primary and secondary carnitine deficiencies in relationship to its role in fatty acid metabolism
11. Myocardial carnitine deficiency in acute myocardial infarction
12. The role of carnitine in the pathogenesis of cardiomegaly in patients with chronic haemodialysis
13. Amelioration of cardiac function by L-carnitine administration in patients on hemodialysis
14. Intravenous L-carnitine increases plasma carnitine, reduces fatigue, and may preserve exercise capacity in hemodialysis patients
15. Response to recombinant human erythropoietin (r-HuEPO) and L-carnitine combination in patients with anemia of end-stage renal disease
16. L-carnitine effects on anemia in hemodialyzed patients treated with erythropoietin
17. Anemia and carnitine supplementation in hemodialyzed patients
18. Three-year survival of patients with heart failure caused by dilated cardiomyopathy and L-carnitine administration
19. Effects of L-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: The L-Carnitine Ecocardiografia Digitalizzata Infarto Miocardico (CEDIM) Trial
20. Efficacy of L-propionylcarnitine treatment in patients with left ventricular dysfunction
21. Effect of carnitine supplementation on cardiac function in hemodyalized children
22. Carnitine and left ventricular function in haemodialysis patients
23. Improvement of myocardial fatty acid metabolism through L-carnitine administration to chronic hemodialysed patients
24. Regulation of carbohydrate metabolism in ischemia and reperfusion
25. Fatty acid utilization in the hypertrophied and failing heart: Molecular regulatory mechanisms